HYPERURICEMIA AS A CARDIOVASCULAR RISK FACTOR
Keywords:
uric acid, cardiovascular riskAbstract
Many epiden1iological studies have suggested a relationship between increased serum levels of uric acid and the risk (f cardiovascular disease. The hyperuricemia is often related to obesity, deslipidemia and arterial hypertension, all these known cardiovascular risk factors. However, some doubts remain about the single role of uric acid as an independent risk factor. The aim of this article is to present bibliographic critical review about the main epidemiological studies that tried to verify the association between the hyperuricania and cardiovascular disease and also tried to identify possible physiopathological mechanisms involved.
Downloads
References
BENGTSSON, C. et al. Hyperuricemia and risk of cardiovascular disease and overall death. Acta Med Scand, v.224, n.6, p.549-555, 1988.
BONORA, E. et al. Relationship of uric acid comcentration to cardiovascular risk fators in young men: role ofobesity and central fat distribution. Int J Obes Relat Metab Disord, v.20, p.975-980, 1996.
CHU, N.F. et al. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol, Rome, v. 16, n.1, p.13-17, 2000.
CORELLA, D. et al. Asociación entre el ácido úrico sérico y otros factores de riesgo cardiovascular en población laboral masculina de Valencia. Rev Clin Esp, Madrid, v.199, n.12, p.806-812, 1999.
CULLETON, B.F. et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med, Philadesphia, v. 131, n. l , p.7-13, 1999.
FACCHINI, F. et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearence and plasma uric acid concentration. JAM4, Chicago, v.266, 11.21, p.3008-3011, 1991.
FANG, J., ALDERMAN, M.H. Serum uric acid and cardiovascular mortality The Nhanes I epidemiologic follow up study 1971-1992. JAM4, Chicago, v.283, n. 18, 1).2404-2410, 2000.
FESSEL, W.J. High uric acid as na indicator of cardiovascular disease. Independence from obesity. Am J Med, Ne Mon, v.68, n.3, p.401-404, 1980.
FREEDMAN, D.S. et al. Relation of serum uric acid to mortality and isquemic heart disease. Am J Epidemiol, Baltimore, v.141, p.637-644, 1995.
JOHNSON, R.J. et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and rebnal disease. Am JKidDis, v.33, n.2, p.225-234, 1999.
LEE, J. et al. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistence syndrome. Am J Epidemiol, Baltimore, v. 142, n.3, p.288-294, 1995.
LEVINE, W. et al. Serum uric acid and 11.5 year mortality af middle age women: findings of the Chicago Heart Association Detections Project in Industry. J Clin Epidemiol, Oxford, v.42, 11.3, p.257-267, 1989.
LEYVA, F. et al. Factors of the metabolic syndrome. Arterioscler Tromb Vas Biol, v. 18, n.2, p.208-214, 1998.
MARTIN-GONZALEZ, R. et al. Hyperuricemia as a risk factor for cerebrovascular accident-a case-control study. Rev New, Paris, v.31, n.l, p.8-13, 2000.
MBENZA, E.L. et al. Is hiperuricemia a risk factor of stroke and coronary heart disease among Africans? Inter J Cardiol, Amsterdam, v. 71, p. 17-22, 1999.
MUSTARD, J.F., MURPHY, E.A., OGRYZLO, M.A. Blood coagulation and platelet economy in subjects with primary gout. CM4J, v.89, p.1207-1211, 1963.
NAKANISHI, N. et al. Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men. Metabolism, Duluth, v.50, 11.6, p.621-626, 2001.
NEWLAND, H. Hyperuricemia in coronary, cerebral and peripheral arterial disease: an explanation. Med Hypotheses, Harlow, v.l, n.4, p.152-155, 1975.
NIETO, F.J. et al. Uric acid and serum antioxidant capacity: a reaction to atheriosclerosis? Atheriosclerosis, Dallas, v.148, n.l, 11131-139, 19--.
SELBY, J.v., FRIEDMAN, G.D., QUESENBERRY, C.P. Precursors of essential hypertension. Am J Epidemiol, Baltimore, v.131, n.6, p.1017-1027, 1990.
STA ESSEN, J. The determinants and prognostic significance of serum uric acid in elderly patients of the european working party on hight blood pressure in the elderly trial. Anl J Med, Newton, v.90, (suppl 3A), p3A-50S-53S, 1991.
STRONG, J.P. Atherosclerotic lesions. Natural history, risk factors and topography. Arch Pathol Lab Med, Chicago, v.116, p.1268, 1992.
TOMITA, M. et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol, v.10, 11.6, p.403-409, 2000.
WARD, H.J. Uric acid as an independent risk factor in the treatment of hypertension. The Lancet, London, v.352, p.670-671, 1998.
WOO, J. etal. Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgrad MedJ, London, v.70, 11.825, p.486-491, 1994.
